// App-Quantinova.ai

2693792 : Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics

Researchers

Presenter

  • Byron L Lam

Principal Investigators

  • M Dominik Fischer

  • Mark E Pennesi

  • Eeva-Marja Kaarina Sankila

  • Frank G. Holz

  • Robert E MacLaren

  • David G Birch

  • Ian M MacDonald

  • Carel C B Hoyng

  • Graeme Black

  • Neil M Bressler

  • Stephen H. Tsang

  • Kimberly E Stepien

  • Michael S Ip

  • Vedran Pavlovic

  • Aniz Girach

Medical Centers

  • Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Ophthalmology and of Pathology and Cell Biology, Columbia University, New York, New York, United States

  • Retinafoundation of the Southwest, Dallas, Texas, United States

  • Casey Eye Institute, Oregon Health and Science University, Portland, California, United States

  • Nuffeild Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom

  • Doheny Eye Institute, David Geffen School of Medicine of the University of California-Los Angeles, Los Angeles, California, United States

  • Wilmer Eye Institute, The Johns Hopkins University, Baltimore, Maryland, United States

  • Dept. of Ophthalmology, University Clinics, Bonn, Germany

  • Department of Urology, Helsinki University Hospital, Helsinki, Finland, Helsinki, Finland.

  • Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States

  • Nightstar Therapeutics plc, London, United Kingdom

  • Center of Ophthalmology, University Tuebingen, Tuebingen, Germany

  • Bascom Palmer Eye Institute, University of Miam, Miami, Florida, United States

  • Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

Locations

  • Canada

  • Netherlands

  • United States

  • United Kingdom

  • Germany

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A